HKHiroko Kuroki

Hiroko Kuroki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hiroko Kuroki has a total of 4 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparison of Aptima and hybrid capture‐2 HPV tests and Pap test in the referral population in Japan

    by Hiroko Kuroki, Jinichi Sakamoto, Takeo Shibata, Masahiro Takakura, Toshiyuki Sasagawa

    The Aptima human papillomavirus (HPV) test (APTIMA) detects E6‐E7 mRNA in abnormal cells in the uterine cervix. To investigate the accuracy of APTIMA for cervical cancer screening in Japan, 423 subjects, mostly referrals with abnormal cytology or being followed up for cervical intraepithelial neoplasia (CIN)1, were screened using two HPV tests, hybrid capture 2 (HC2) and APTIMA, and by the Pap test. Colposcopy was conducted in all subjects with a positive result in either test type. HPV genotyping was performed by Genosearch‐31.A result of atypical squamous cells‐undetermined significance (ASC‐US) or worse on the HC2 test (ASC‐US‐HC2), and low‐grade squamous intraepithelial lesion (LSIL) or worse (LSIL+) on the Pap test, was regarded as positive. APTIMA (97.5%) was more sensitive than LSIL+ (85.1%) for detecting CIN2 or worse (CIN2+) (McNemar test; p = .0003), and more sensitive (98.6%) than ASC‐US‐HC2 (92.7%) for detecting CIN3+. APTIMA and HC2 had similar sensitivities. HPV genotyping revealed that CIN2/3 with high‐risk HPV (HR‐HPV) was overlooked in five cases by ASC‐US‐HC2, and in four cases by HC2, while no such lesions were missed by APTIMA. Thus, APTIMA might be superior to HC2 for primary HPV screening in Japan. One cancer case positive for HPV67 (potentially high risk, [pHR]) was overlooked by Pap test and both HPV tests, suggesting a need for a new HPV test able to detect pHR‐HPV types.


  • Survey on the trends in uterine cervical cancer screening in Japanese women: The efficacy of free coupons in the screening

    by Hiroko Kuroki

    Aims: In Japan, cytological examination is performed for uterine cervical cancer screening, but the rate of participation in these programs is low. Between October 1, 2009 and March 31, 2010, free coupons for uterine cervical cancer screening were distributed to Japanese women. The Fukuoka Tuberculosis Prevention Center investigated the trends in uterine cervical cancer screening participation of Japanese women in the 6-month screening program. Material and Methods: The subjects were 1523 women who underwent cervical smear cytology at the Fukuoka Tuberculosis Prevention Center between October 1, 2009 and March 31, 2010. A questionnaire survey based on multiple questions was performed to evaluate awareness about uterine cervical cancer screening for women undergoing screening by cervical smear cytology. Results: The results of the study showed that the rate of women undergoing repeated screening was high among women who underwent screening as part of health checkups that were paid for by the employer according to the recommendations of the Industrial Safety and Health Act. Women who had not undergone the screening previously were motivated to participate after receiving the free coupons. Conclusions: The distribution of free coupons serves as an initial step towards promoting awareness of preventive measures against uterine cervical cancer.